In this Issue
The OR is changing—are you keeping up?
By Allen C. Ho, MD, and Robert L. Avery, MD
EyewireTV sits down with Allergan to discuss how the company’s merger with Pfizer will affect the retina industry.
By Steve Daily, Executive Editor, Eyewire
BUSINESS OF RETINA
More advice for fellows on disciplined self-finance.
By Jayanth Sridhar, MD
Innovations in Retina
Many efforts are under way to improve drug delivery to the back of the eye.
By Aron Shapiro
Coding for Retina
Pointers for avoiding confusion and steering clear of problems.
By Riva Lee Asbell
EHR systems are not one-size-fits-all. Here are some tips for selecting a system that is right for your retina practice.
By Scott Heintzeman and Dan Montzka, MD
Proper choice of vitreoretinal techniques and endotamponade can lead to a high rate of anatomic success.
By Ogugua N. Okonkwo, MD, FRCS(Edin), FWACS
Hazy media preoperatively may obscure subtle clues to retinal conditions.
By Jay Chhablani, MD, and Vivek Gupta, MBBS
A rundown of methods for releasing drugs into the eye.
By Randall V. Wong, MD
Tissue-sparing laser provides positive results.
By Margaret Wong, MD, and Robert L. Halpern, MD
Single-center experience with the Zeiss Rescan 700 microscope-mounted OCT system.
By Matthew B. Donovan, BS; Amir Mohsenin, MD, PhD; Thomas A. Albini, MD; Sonia H. Yoo, MD; Harry W. Flynn Jr, MD; Janet L. Davis, MD; William W. Culbertson, MD; and Audina M. Berrocal, MD
SPECIAL FOCUS: INSIDE THE TREATMENT PIPELINE
Using encapsulated cell technology, a novel device may some day be used to treat inadequate oxygenation associated with common diseases.
By Logan Christensen, MD, and Jeffrey L. Olson, MD
Results of a phase 2 study suggest efficacy and safety plus additional antiangiogenic benefit.
By Peter K. Kaiser, MD
COVER FOCUS: Vitreoretinal Techniques & Technologies
The field of retina continues to stay innovative, offering promise for a future of better outcomes.
By Paulo Ricardo Chaves de Oliveira, MD, and David Robert Chow, MD, FRCS
Common questions associated with this anomaly are addressed.
By Roomasa Channa, MD, and Adrienne W. Scott, MD
Taking stock of currently available vitrectomy systems that could be used in an office setting.
By John D. Pitcher III, MD
Why this imaging technology deserves a place in the surgical setting.
By Mehnaz Khan, MD, MS, and Justis P. Ehlers, MD
As technology improves and progresses, surgical procedures will become automated, more efficient, and safer.
By Theodore Leng, MD, MS
The Case for Phacovirectomy By Timothy G. Murray, MD, MBA
A Japanese Perspective By Yusuke Oshima, MD, PhD
Geeta Lalwani, MD, is a vitreoretinal surgeon at Rocky Mountain Retina Associates in Boulder, Colo.